AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2024
Sep 18, 2024
32106_dirs_2024-09-18_ad6e329a-498d-4996-93c8-6b70a7764c21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2024-07-11
Reporting Person: Mathew Aby J. (EVP & Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-11 | Common Stock | S | 313 | $20.54 | Disposed | 318170 | Direct |
| 2024-08-21 | Common Stock | S | 111 | $25.61 | Disposed | 318059 | Direct |
| 2024-09-16 | Common Stock | S | 343 | $25.12 | Disposed | 317716 | Direct |
Footnotes
F1: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F2: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F3: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.